Large-Volume Parenteral Solutions

MEETING DIFFERING CLINICAL REQUIREMENTS

Patients will have differing fluid and electrolyte needs based on their clinical history, their current condition and medications, and the results of clinical monitoring and laboratory tests.Baxter offers a wide range of large volume parenteral solutions.

Balanced/buffered solutions that have an electrolyte composition close to that of plasma are associated with fewer complications and lower mortality than solutions with higher sodium and chloride levels and may result in considerable savings for hospitals and pharmacies.2,3

Hypotonic buffered solutions containing glucose may help optimise maintenance therapy.4

Unbalanced solutions are appropriate for patients with specific requirements.5

Close up shot of IV bag

ENHANCING FLUID DELIVERY WITH VIAFLO CONTAINERS

Viaflo intravenous bags provide flexibility, versatility and a closed system. They are free of latex, polyvinyl chloride (PVC) and Di(2-ethylhexyl) phthalate (DEHP).

Female healthcare professional wearing medical gloves holds and reads an IV bag. A patient is reclined in a hospital bed behind her.

OPTIMISING FLUID MANAGEMENT WITH THE EQUILIBRIA PROGRAMME

Since one in five patients may suffer complications or morbidity due to inappropriate fluid administration, it is critical that fluids are managed judiciously, according to individual patient needs.1 Baxter developed the Equilibria Fluid Optimisation Programme to support clinicians in making the right fluid choices and implementing appropriate fluid management practices hospital-wide.

Prescribing Information for 0.9% Sodium Chloride (UK & ROI) - ref UK-ROI/SG152/17-0001(3). 

Adverse Events and any drug or medical device product quality complaints (including suspected defective medicines or medical device adverse incidents) should be reported.

-  For the UK reporting forms and information can be found at www.mhra.gov.uk/yellowcard.

-  For Ireland report to the Health Products Regulatory Authority (HPRA) using a Yellow Card obtained from the HPRA, via the online system (www.hpra.ie) or by telephone on +353 (0)1-6764971.

-  Adverse Events relating to Baxter products can also be reported direct to Baxter Pharmacovigilance on +44 (0)1635 206360, or by email to [email protected].

-  Drug or medical device product quality complaints relating to Baxter products can be reported directly to Baxter Healthcare Ltd:

-  In the UK +44 (0)1604 704603, or by email to [email protected].

-  In Ireland on +353 (0)1 2065500 or by email to [email protected].

-  Alternatively please report directly to your Baxter Representative, who will take the details and forward to the Baxter Country Quality Assurance Team.

Rx only. For safe and proper use of the products mentioned herein, please refer to the appropriate Operator's Manual or Instructions for Use.

Baxter, Equilibria and Viaflo are trademarks of Baxter International Inc. or its subsidiaries.